Cytosorbents (CTSO) Tops Q1 EPS by 3c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $7 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• Circle split as Morgan Stanley cuts to Underweight, TD Cowen starts at Buy
• Sweetgreen drops 7%, Yum falls 2% as Michigan cyclospora deaths rise to 2